Literature DB >> 7972215

Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines.

C P Reynolds1, P F Schindler, D M Jones, J L Gentile, R T Proffitt, P A Einhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7972215

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  13 in total

1.  Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins.

Authors:  Michael D Hadjidaniel; C Patrick Reynolds
Journal:  Mol Cancer Ther       Date:  2010-12       Impact factor: 6.261

2.  Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.

Authors:  Pei-Li Yao; Liping Chen; Tomasz P Dobrzański; Bokai Zhu; Boo-Hyon Kang; Rolf Müller; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Carcinog       Date:  2017-01-13       Impact factor: 4.784

Review 3.  Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

Authors:  C P Reynolds
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

4.  Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.

Authors:  Poonam Sonawane; Hwang Eui Cho; Ashujit Tagde; Dattesh Verlekar; Alice L Yu; C Patrick Reynolds; Min H Kang
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

5.  ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.

Authors:  Sidong Huang; Jamila Laoukili; Mirjam T Epping; Jan Koster; Michael Hölzel; Bart A Westerman; Wouter Nijkamp; Akiko Hata; Shahab Asgharzadeh; Robert C Seeger; Rogier Versteeg; Roderick L Beijersbergen; René Bernards
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

Review 6.  Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer.

Authors:  Faith Stevison; Jing Jing; Sasmita Tripathy; Nina Isoherranen
Journal:  Adv Pharmacol       Date:  2015-05-27

7.  Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma.

Authors:  Gareth J Veal; Julie Errington; Sophie E Rowbotham; Nicola A Illingworth; Ghada Malik; Michael Cole; Ann K Daly; Andrew D J Pearson; Alan V Boddy
Journal:  Clin Cancer Res       Date:  2012-10-19       Impact factor: 12.531

8.  Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.

Authors:  Yu-Yin Shih; Hsinyu Lee; Akira Nakagawara; Hseuh-Fen Juan; Yung-Ming Jeng; Yeou-Guang Tsay; Dong-Tsamn Lin; Fon-Jou Hsieh; Chien-Yuan Pan; Wen-Ming Hsu; Yung-Feng Liao
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

9.  Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells.

Authors:  J L Armstrong; M Ruiz; A V Boddy; C P F Redfern; A D J Pearson; G J Veal
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

10.  High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.

Authors:  Paolo Romania; Aurora Castellano; Cecilia Surace; Arianna Citti; Maria Antonietta De Ioris; Pietro Sirleto; Marilena De Mariano; Luca Longo; Renata Boldrini; Adriano Angioni; Franco Locatelli; Doriana Fruci
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.